- Home
- ALPS vs LFCR Comparison
ALPS vs LFCR Comparison
Compare ALPS & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALPS | LFCR |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.7M | 143.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ALPS | LFCR |
|---|---|---|
| Price | $0.98 | $5.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 13.1K | ★ 610.5K |
| Earning Date | 07-24-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.56 | $3.63 |
| 52 Week High | $1.72 | $8.98 |
Technical Indicators
Market Signals| Indicator | ALPS | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 56.17 |
| Support Level | $0.85 | $3.63 |
| Resistance Level | $1.02 | $8.47 |
| Average True Range (ATR) | 0.06 | 0.28 |
| MACD | -0.01 | 0.26 |
| Stochastic Oscillator | 45.45 | 94.01 |
Price Performance
Historical ComparisonAbout ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.